Obesity, type 2 diabetes and the metabolic syndrome: pathophysiologic relationships and guidelines for surgical intervention
No Thumbnail Available
Authors
Genser, Laurent
Casella Mariolo, James Rossario
Castagneto-Gissey, Lidia
Panagiotopoulos, Spyros
Rubino, Francesco
Check for full-text access
Issue Date
2016
Type
Article
Language
Keywords
Alternative Title
Abstract
Several gastrointestinal (GI) operations originally developed for the treatment of severe obesity (bariatric surgery) promote sustained weight loss as well as dramatic, durable improvements of insulin-resistant states, most notably type 2 diabetes mellitus (T2DM). Experimental evidence shows that some rearrangements of GI anatomy can directly affect glucose homeostasis, insulin sensitivity, and inflammation, supporting the idea that the GI tract is a biologically rational target for interventions aimed at correcting pathophysiologic aspects of cardiometabolic disorders. This article reviews the pathophysiology of metabolic disease and the role of bariatric/metabolic surgery in current clinical guidelines for the treatment of obesity and T2DM.
Description
Citation
Publisher
License
Journal
Surgical Clinics of North America
Volume
96
Issue
4
